US 12331132
Multispecific polypeptide constructs having constrained CD3 binding and related methods and uses
granted A61PA61P35/00
Quick answer
US patent 12331132 (Multispecific polypeptide constructs having constrained CD3 binding and related methods and uses) held by Inhibrx Biosciences, Inc. expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inhibrx Biosciences, Inc.
- Grant date
- Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P35/00